-Universitätsklinikder

[136] Radbruch, L., Sabatowski, R., Loick, G., Jonen-Thielemann, I., Elsner, F.,
Hörmann, E. (2000). MIDOS--validation of a minimal documentation system
for palliative medicine. Schmerz 14 (4), 231–239
[137] Radbruch, L., Wenk, R., de Lima, L., Scholten, W. (2013). Die Essenz der
Palliativmedizin – Essentielle Medikamente für die Palliativmedizin in WHO-
Liste aufgenommen. Zeitschrift für Palliativmedizin 14 (06), 247–248
[138] Rayment, C., Bennett, M. I., Aass, N., Hjermstad, M. J., Kaasa, S. (2011).
Cancer neuropathic pain: Prevalence and associated factors in the
European palliative care research collaborative computerised symptom
assessment study. European Journal of Palliative Care 1 (230), 1
[139] Rayment, C., Hjermstad, M. J., Aass, N., Kaasa, S., Caraceni, A., Strasser,
F., Heitzer, E., Fainsinger, R., Bennett, M. I., On behalf of the European
Palliative Care Research Collaborative (EPCRC). (2013). Neuropathic
cancer pain: Prevalence, severity, analgesics and impact from the
European Palliative Care Research Collaborative-Computerised Symptom
Assessment study. Palliative Medicine 27 (8), 714–721
[140] Refresher course - aktuelles Wissen für Anästhesisten: Nr. 24, Juni 1998,
Frankfurt S.46. (1998). Springer, Berlin 45–64
[141] Regan, J. M., Peng, P. (2000). Neurophysiology of cancer pain. Cancer
Control 7 (2), 111–119
[142] Reid, C. M., Forbes, K. (2007). Pain in patients with cancer: Still a long way
to go. PAIN 132 (3), 229–230
[143] Risks of agranulocytosis and aplastic anemia. A first report of their relation
to drug use with special reference to analgesics. The International
Agranulocytosis and Aplastic Anemia Study. (1986). JAMA 256 (13), 1749–
1757
[144] Rolke, R., Birklein, F. (2010). Neuropathische Komponente bei
Tumorschmerzen: Ein Leitfaden für Diagnostik und Therapie. Angew
Schmerzther Palliativmed 2, 1–10
[145] Rothstein, D., Zenz, M. (2009). Therapie chronischer Schmerzen. Der
Internist 50 (9), 1161–1168
76